New Study: States Could Save Up to $1.8 Billion Annually by Prioritizing Lower-Cost Biosimilar Medicines
Pacific Research Institute analysis finds taxpayers and state employees could benefit from greater use of safe, effective alternatives to expensive biologic drugs SACRAMENTO, Calif., July 7, 2026 /PRNewswire/ -- At a time when states across the country are grappling with significant...
Pacific Research Institute analysis finds taxpayers and state employees could benefit from greater use of safe, effective alternatives to expensive biologic drugs SACRAMENTO, Calif., July 7, 2026 /PRNewswire/ -- At a time when states across the country are grappling with significant...
Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.